India approves leprosy vaccineBMJ 1998; 316 doi: http://dx.doi.org/10.1136/bmj.316.7129.411f (Published 07 February 1998) Cite this as: BMJ 1998;316:411
- Ganapati Mudur
- New Delhi
A vaccine against leprosy has been approved by India's drug control agency and is to be incorporated into the national eradication programme. The vaccine is designed to be used as an adjunct to standard multidrug therapy to accelerate healing and reduce the duration and cost of the treatment.
The vaccine, developed at the National Institute of Immunology in New Delhi, is said to be the first in the world that stimulates the immune system to kill Mycobacterium leprae. The vaccine, administered intradermally, is prepared from a killed non-pathogenic strain of Mycobacterium, first isolated in the mid-1970s from the sputum of a patient with tuberculosis …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial